Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.23M | 5.13M | 4.21M | 4.33M | 4.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.23M | 5.13M | 4.21M | 4.33M | 4.34M |
| Cost of Revenue | 1.92M | 1.88M | 1.42M | 1.46M | 1.09M |
| Gross Profit | 3.31M | 3.24M | 2.79M | 2.87M | 3.26M |
| SG&A Expenses | 3.05M | 2.98M | 3.30M | 3.39M | 2.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 763.60K | 747.80K | 853.00K | 877.10K | 824.70K |
| Total Operating Expenses | 6.39M | 6.25M | 5.97M | 6.13M | 5.44M |
| Operating Income | -1.15M | -1.13M | -1.75M | -1.80M | -1.09M |
| Income Before Tax | -1.17M | -1.15M | -1.76M | -1.81M | -1.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.17M | -1.15M | -1.76M | -1.81M | -1.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.17M | -1.15M | -1.76M | -1.81M | -1.04M |
| EBIT | -1.15M | -1.13M | -1.75M | -1.80M | -1.09M |
| EBITDA | -492.90K | -482.70K | -1.69M | -1.74M | -179.90K |
| EPS Basic | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 265.14M | 265.14M | 229.53M | 229.53M | 217.60M |
| Average Diluted Shares Outstanding | 265.14M | 265.14M | 229.53M | 229.53M | 217.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |